Scientific Reports · 2023 · 26 citations · 25 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsEnzyme InhibitionLigand-based DesignMolecular ModelingQuantitative Structure-activity RelationshipsStructure-activity Relationship AnalysisActive Site CharacterizationAntidiabetic ActivityAntidiabetic Drug TherapyChemical Structure-activity RelationshipsGlycosidase InhibitionMechanism-based Drug DesignMolecular Docking AnalysisMolecular Property-based Design
Abstract In the present study, new structural variants of 4-hydroxyquinolinone-hydrazones were designed and synthesized. The structure elucidation of the synthetic derivatives 6a–o was carried out using different spectroscopic techniques including FTIR, 1 H-NMR, 13 C-NMR, and elemental analysis, and their α-glucosidase inhibitory activity was also determined. The synthetic molecules 6a–o exhibited good α-glucosidase inhibition with IC 50 values ranging between 93.5 ± 0.6 to 575.6 ± 0.4 µM as compared to the standard acarbose (IC 50 = 752.0 ± 2.0 µM). Structure–activity relationships of this series were established which is mainly based on the position and nature of the substituent on the benzylidene ring. A kinetic study of the active compounds 6l and 6m as the most potent derivatives were also carried out to confirm the mode of inhibition. The binding interactions of the most active compounds within the active site of the enzyme were determined by molecular docking and molecular dynamic simulations.
25
8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential
Yuning Song, Hao Xu, Wen‐Ming Chen et al. · MedChemComm · 2014 · 232 citations
Muhammad Taha, Nor Hadiani Ismail, Salima Lalani et al. · European Journal of Medicinal Chemistry · 2015 · 163 citations · Full text
Li Wang, Gerard Esteban, Masaki Ojima et al. · European Journal of Medicinal Chemistry · 2014 · 138 citations · Full text